期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Hepatitis C virus and non-Hodgkin's lymphomas:Metaanalysisof epidemiology data and therapy options 被引量:3
1
作者 Gabriele Pozzato Cesare Mazzaro +6 位作者 Luigino Dal Maso endri mauro Francesca Zorat Giulia Moratelli PietroBulian Diego Serraino Valter Gattei 《World Journal of Hepatology》 CAS 2016年第2期107-116,共10页
Hepatitis C virus(HCV) is a global health problem affecting a large fraction of the world's population: This virus is able to determine both hepatic and extrahepatic diseases. Mixed cryoglobulinemia, a B-cell &quo... Hepatitis C virus(HCV) is a global health problem affecting a large fraction of the world's population: This virus is able to determine both hepatic and extrahepatic diseases. Mixed cryoglobulinemia, a B-cell "benign" lymphoproliferative disorders, represents the most closely related as well as the most investigated HCVrelated extrahepatic disorder. Since this virus is able to determine extrahepatic [non-Hodgkin's lymphoma(NHL)] as well as hepatic malignancies(hepatocellular carcinoma), HCV has been included among human cancer viruses. The most common histological types of HCV-associated NHL are the marginal zone, the lymphoplasmacytic and diffuse large cell lymphomas. The role of the HCV in the pathogenesis of the B-cell lymphoproliferative disorders is confirmed also by the responsiveness of the NHL to antiviral therapy. The purpose of this review is to provide an overview of the recent literature and a meta analysis of the epidemiology data, to explain the role of HCV in the development of NHL's lymphoma. Furthermore, the possibility to treat these HCV-related NHL with the antiviral therapy or with other therapeutic options, like chemotherapy, is also discussed. 展开更多
关键词 HEPATITIS C VIRUS Non-Hodgkin's lymphoma HEPATITIS C VIRUS GENOTYPES Alpha-interferon
下载PDF
Adult Langerhans cell histiocytosis and immunomodulatory drugs:Review and analysis of thirty-four case reports
2
作者 endri mauro Piero Maria Stefani Filippo Gherlinzoni 《World Journal of Hematology》 2019年第1期1-9,共9页
Langerhans cell histiocytosis(LCH)is a rare neoplastic disease in dendritic cells.LCH is classified as either a single-system(SS)or multisystem(MS)disease.There is not a standard first-line treatment for LCH in adults... Langerhans cell histiocytosis(LCH)is a rare neoplastic disease in dendritic cells.LCH is classified as either a single-system(SS)or multisystem(MS)disease.There is not a standard first-line treatment for LCH in adults.We analyzed the efficacy and safety of immunomodulatory drugs(IMiDs)by searching PubMed/MEDLINE for case reports previously published.The clinical response(nonactive disease or active disease that regressed)was 94%in SS and 53%in MS.IMiDs should only be considered for adults with cutaneous SS involvement;in MS,they should be used only for patients not eligible for more aggressive treatments. 展开更多
关键词 Langerhans cell histiocytosis Immunomodulatory drugs THALIDOMIDE LENALIDOMIDE
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部